Safety and Pharmacokinetic Study of Glp 1 Receptor Agonists Exenatide Administered once Weekly and Metformin Administered Daily With Type 2 Diabetes Mellitus

dc.contributor.guide	Soni,Rupesh
dc.coverage.spatial
dc.creator.researcher	Nehal Jamali, Arshad
dc.date.accessioned	2025-08-20T11:15:51Z
dc.date.available	2025-08-20T11:15:51Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	117p.
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/658427
dc.language	English
dc.publisher.institution	Faculty of Pharmacy(BRNCOP)
dc.publisher.place	Mandsaur
dc.publisher.university	Mandsaur University
dc.relation	45
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Safety and Pharmacokinetic Study of Glp 1 Receptor Agonists Exenatide Administered once Weekly and Metformin Administered Daily With Type 2 Diabetes Mellitus
dc.title.alternative
dc.type.degree	Ph.D.